Quarterly Outlook
Macro Outlook: The US rate cut cycle has begun
Peter Garnry
Chief Investment Strategist
Chief Investment Strategist
Summary: As we have written about in several equity notes, the bubble stocks segment has been under enormous pressure this year and in recent weeks the destruction in market value has intensified at a blistering pace. The tailwind from the pandemic that has benefitted many technology companies is easing faster than expected and the worsening inflation outlook is making many growth investors wary of the future direction for interest rates which play an important role in equity valuations of growth stocks. We touch on DocuSign and its Q4 revenue miss last night which caused a 30% plunge in its shares underscoring the fragility in growth stocks with high expectations.
The fallout in bubble stocks show importance of balance
In yesterday’s equity note, we discussed bubble stocks and how this group of stocks have been under pressure since February as the pandemic tailwind on growth has eased and the inflation outlook has worsened causing markets to readjust their interest rate outlook. Low interest rates have been the key driver of excessive valuations in this bubble segment and now as the tide is turning investors are readjusting their exposure. As we move into 2022, we will reiterate our view on equities that we like semiconductors, commodity sector, logistics, cyber security, mega caps, financial trading companies (a play on interest rates and volatility), and battery, which most of them are plays on the physical world making a comeback against the digital world. In a rising inflationary environment our preferred themes can make growth portfolio with exposure to bubble stocks more balanced in terms of risk.
Momentum crash and Danish equities under pressure
Like our bubble basket, Morgan Stanley has their own most crowded stocks basket which has just dropped more than 10% relative to the S&P 500, the most on record since 2013 underscoring the massive destruction that is currently taking place. While Tracy Alloway from Bloomberg calls it a new “quant crisis”, our view is that it is more a classic momentum crash as momentum strategies sitting on fat gains over the past 18 months are drastically reducing positions. When we reach the bottom is very uncertain but if we are in a momentum crash then it is the illiquidity that drives the explosive price action.
In our recent string of equity notes on interest rate sensitivity and bubble stocks we also mentioned Danish equities as being interest rate sensitive together with other equity markets such as the Netherlands, Switzerland, United States, and India. But given the recent weeks price action it seems there is an overlap to the bubble stocks selloff suggesting the readjustments in equities are more profound.
DocuSign shares plunging 30% show fragility for growth stocks
Another sign of the stress in the bubble stocks segment of the equity market is the 30% plunge in DocuSign, the leader in electronic signature, following a Q4 (ending 31 January 2022) revenue guidance missing estimates; the revenue guidance was $557-563mn vs est. $574mn. The price reaction shows how fragile these stocks are to a small change in revenue expectations and clearly the risks associated with bubble stocks. We should point out, that DocuSign does not fit all criteria for being added to our bubble stocks basket because the 12-month forward earnings expectations are positive whereas we require those to be negative to be called a bubble stock. The revenue miss has caused sell-side analysts to drastically cut the median price target to $275 from around previously $330 against a close of $164 in extended trading yesterday.
Disclaimer
The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)